CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Val Curran

OPENALEX: A5021720240↗OPENALEX: A5061200799↗ORCID: 0000-0001-6041-5214↗

Affiliations

Organizations

Australian Catholic Universityauthorship · AU Central Institute of Mental Healthauthorship · DE Health Data Research UKauthorship · GB Heidelberg Universityauthorship · DE MRC Cancer Unitauthorship · GB National Institute for Health and Care Researchauthorship · GB UCL Biomedical Research Centreauthorship · GB University College Hospitalauthorship · GB University College Londonauthorship · GB University Hospital Heidelbergauthorship · DE University of Londonauthorship · GB

Public evidence

32 connected articles

The association between cannabis use and brain reward anticipation: a 12-month longitudinal study of adults and adolescents who use cannabis and age-matched controls2026 · PubMed Central Open Access Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study.2025 · Europe PMC Longitudinal study of risk factors predicting cannabis use disorder in UK young adults and adolescents.2025 · Europe PMC Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks.2024 · Europe PMC The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study.2024 · Europe PMC Measuring white matter microstructure in 1,457 cannabis users and 1,441 controls: A systematic review of diffusion-weighted MRI studies.2023 · PubMed Central Open Access Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder.2023 · Europe PMC Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder.2023 · PubMed Central Open Access Anhedonia, Apathy, Pleasure, and Effort-Based Decision-Making in Adult and Adolescent Cannabis Users and Controls.2023 · PubMed Central Open Access

Registered research

Connected studies

A Phase IIa/b, Randomised, Double-blind, Placebo-controlled, Single-site, Parallel Group Clinical Trial to Examine Cannabidiol (CBD) as a Pharmacological Treatment for Cannabis Dependence.nct02044809 Do Adolescents and Adults Differ in Their Acute Subjective, Behavioural and Neural Responses to Cannabis, With and Without Cannabidiol?nct04851392 Evaluating the Efficacy of Cannabidiol for Reducing Cigarette Usenct06218056

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment.

2023 · PubMed Central Open Access

Individual and combined effects of cannabidiol and Δ<sup>9</sup>-tetrahydrocannabinol on striato-cortical connectivity in the human brain.2022 · Europe PMC

Neural responses to reward anticipation and feedback in adult and adolescent cannabis users and controls.2022 · PubMed Central Open Access

The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls.2022 · PubMed Central Open Access

The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls.2022 · PubMed Central Open Access

A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products.2022 · Europe PMC

Cannabis based medicines and cannabis dependence: A critical review of issues and evidence.2021 · Europe PMC

Illicit Drug Use and Associated Problems in the Nightlife Scene: A Potential Setting for Prevention.2021 · PubMed Central Open Access

Medical cannabis in the UK: From principle to practice.2020 · Europe PMC

Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?2020 · PubMed Central Open Access

Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?2019 · Europe PMC

Non-Dependent and Dependent Daily Cannabis Users Differ in Mental Health but Not Prospective Memory Ability.2018 · PubMed Central Open Access

Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.2018 · Europe PMC

Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal.2018 · PubMed Central Open Access

Cannabis Dampens the Effects of Music in Brain Regions Sensitive to Reward and Emotion.2018 · PubMed Central Open Access

Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users.2017 · PubMed Central Open Access

Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial.2017 · PubMed Central Open Access

Salience attribution and its relationship to cannabis-induced psychotic symptoms.2016 · PubMed Central Open Access

AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers.2016 · PubMed Central Open Access

Associations between cigarette smoking and cannabis dependence: A longitudinal study of young cannabis users in the United Kingdom2015 · PubMed Central Open Access

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users2015 · PubMed Central Open Access

Val Curran - Medical Cannabis Research Engine